Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.31 is 94% below its 5-year average of 5.05, near the low end of its 5-year range (0.00–19.41).
As of the fiscal period ended Wednesday, December 31, 2025. 61.93% below its 12-month average of 0.81.
Reported quarterly quick ratio; no daily interpolation. Q4 FY2025 (2025-12-31): 0.31.
QUICK RATIO (ACID-TEST)
0.31
QUICK RATIO (ACID-TEST) AVG TTM
0.81
QUICK RATIO (ACID-TEST) AVG 3Y
1.32
QUICK RATIO (ACID-TEST) AVG 5Y
5.05
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-61.93%
CURRENT VS 3Y AVG
-76.63%
CURRENT VS 5Y AVG
-93.88%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.25
median of 789 covered companies
CURRENT VS SECTOR MEDIAN
-90.49%
vs the sector median at left
NeuroSense Therapeutics Ltd.
Market Cap
$6.91M
Quick Ratio (Acid-Test)
0.31
TTM Avg
0.81
3Y Avg
1.32
5Y Avg
5.05
Market Cap
$6.99M
Quick Ratio (Acid-Test)
2.61
TTM Avg
3.40
3Y Avg
4.86
5Y Avg
5.09
Market Cap
$7.00M
Quick Ratio (Acid-Test)
0.18
TTM Avg
0.90
3Y Avg
2.06
5Y Avg
1.76
Market Cap
$6.78M
Quick Ratio (Acid-Test)
1.52
TTM Avg
3.93
3Y Avg
10.24
5Y Avg
10.80
Market Cap
$7.07M
Quick Ratio (Acid-Test)
45.95
TTM Avg
58.73
3Y Avg
40.89
5Y Avg
40.89
Market Cap
$6.74M
Quick Ratio (Acid-Test)
16.20
TTM Avg
7.76
3Y Avg
4.60
5Y Avg
3.08
Market Cap
$7.42M
Quick Ratio (Acid-Test)
0.95
TTM Avg
9.81
3Y Avg
5.30
5Y Avg
4.51
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeuroSense Therapeutics Ltd. (NRSN) | $6.91M | 0.31 | 0.81 | 1.32 | 5.05 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.99M | 2.61 | 3.40 | 4.86 | 5.09 |
| Mangoceuticals, Inc. (MGRX)vs › | $7.00M | 0.18 | 0.90 | 2.06 | 1.76 |
| Exicure, Inc. (XCUR)vs › | $6.82M | 0.56 | 2.82 | 3.15 | 3.36 |
| Co-Diagnostics, Inc. (CODX)vs › | $6.78M | 1.52 | 3.93 | 10.24 | 10.80 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.07M | 45.95 | 58.73 | 40.89 | 40.89 |
| Aclarion, Inc. (ACON)vs › | $6.74M | 16.20 | 7.76 | 4.60 | 3.08 |
| KALA BIO, Inc. (KALA)vs › | $7.12M | 6.88 | 3.46 | 4.15 | 4.53 |
| Skye Bioscience, Inc. (SKYE)vs › | $7.42M | 0.95 | 9.81 | 5.30 | 4.51 |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.45M | N/A | 2.00 | 1.31 | 1.05 |
Quick Ratio
0.31
Excludes inventory
Current Ratio
0.31
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2025-12-31 | 0.31 |
| 2025-09-30 | 0.13 |
| 2025-06-30 | 0.71 |
| 2025-03-31 | 0.71 |
| 2024-12-31 | 2.21 |
| 2024-09-30 | 0.21 |
| 2024-06-30 | 0.46 |
| 2024-03-31 | 0.26 |
| 2023-12-31 | 0.84 |
| 2023-09-30 | 1.80 |
| 2023-06-30 | 2.50 |
| 2023-03-31 | 2.78 |
| 2022-12-31 | 4.28 |
| 2022-09-30 | 10.96 |
| 2022-06-30 | 15.09 |
| 2022-03-31 | 11.42 |
| 2021-12-31 | 19.41 |
| 2021-09-30 | 0.00 |
| 2021-06-30 | 8.08 |
| 2021-03-31 | 17.48 |
| 2020-12-31 | 6.38 |
| 2020-09-30 | 6.38 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
